Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferran Sanz

Showing results (1-10 of 135) with videos related to

Pageof 14
Sort By:
Annual Review of Biomedical Data Science|April 1, 2025
Integrative Data Science in Drug Safety Research: Experiences, Challenges, and PerspectivesFerran Sanz
Journal of Computer-Aided Molecular Design|June 27, 2003
Current perspective of information technologies in drug discoveryFerran Sanz, Federico Gago
Frontiers in Pharmacology|October 27, 2018
Development of an Infrastructure for the Prediction of Biological Endpoints in Industrial Environments. Lessons Learned at the eTOX ProjectManuel Pastor, Jordi Quintana, Ferran Sanz
Journal of Medicinal Chemistry|May 14, 2004
Incorporating molecular shape into the alignment-free Grid-Independent DescriptorsFabien Fontaine, Manuel Pastor, Ferran Sanz
Methods in Molecular Biology (Clifton, N.J.)|February 21, 2022
Development of In Silico Methods for Toxicity Prediction in Collaboration Between Academia and the Pharmaceutical IndustryManuel Pastor, Ferran Sanz, Frank Bringezu
Archives of Toxicology|November 11, 2015
Toward a unifying strategy for the structure-based prediction of toxicological endpointsPau Carrió, Ferran Sanz, Manuel Pastor
Bioinformatics (Oxford, England)|October 3, 2017
An automated tool for obtaining QSAR-ready series of compounds using semantic web technologiesOriol López-Massaguer, Ferran Sanz, Manuel Pastor
Bioinformatics (Oxford, England)|August 3, 2006
OSIRIS: a tool for retrieving literature about sequence variantsJulio Bonis, Laura Inés Furlong, Ferran Sanz
Current Opinion in Pharmacology|September 12, 2018
In silico models in drug development: where we areJanet Piñero, Laura I Furlong, Ferran Sanz
Atencion Primaria|May 12, 2009
[Health information on the Internet and trust marks as quality indicators: vaccines case study]Miguel Angel Mayer, Angela Leis, Ferran Sanz
Pageof 14

Showing results (1-10 of 135) with videos related to

Sort By:
Pageof 14
Annual Review of Biomedical Data Science|April 1, 2025
Integrative Data Science in Drug Safety Research: Experiences, Challenges, and PerspectivesFerran Sanz
Journal of Computer-Aided Molecular Design|June 27, 2003
Current perspective of information technologies in drug discoveryFerran Sanz, Federico Gago
Frontiers in Pharmacology|October 27, 2018
Development of an Infrastructure for the Prediction of Biological Endpoints in Industrial Environments. Lessons Learned at the eTOX ProjectManuel Pastor, Jordi Quintana, Ferran Sanz
Journal of Medicinal Chemistry|May 14, 2004
Incorporating molecular shape into the alignment-free Grid-Independent DescriptorsFabien Fontaine, Manuel Pastor, Ferran Sanz
Methods in Molecular Biology (Clifton, N.J.)|February 21, 2022
Development of In Silico Methods for Toxicity Prediction in Collaboration Between Academia and the Pharmaceutical IndustryManuel Pastor, Ferran Sanz, Frank Bringezu
Archives of Toxicology|November 11, 2015
Toward a unifying strategy for the structure-based prediction of toxicological endpointsPau Carrió, Ferran Sanz, Manuel Pastor
Bioinformatics (Oxford, England)|October 3, 2017
An automated tool for obtaining QSAR-ready series of compounds using semantic web technologiesOriol López-Massaguer, Ferran Sanz, Manuel Pastor
Bioinformatics (Oxford, England)|August 3, 2006
OSIRIS: a tool for retrieving literature about sequence variantsJulio Bonis, Laura Inés Furlong, Ferran Sanz
Current Opinion in Pharmacology|September 12, 2018
In silico models in drug development: where we areJanet Piñero, Laura I Furlong, Ferran Sanz
Atencion Primaria|May 12, 2009
[Health information on the Internet and trust marks as quality indicators: vaccines case study]Miguel Angel Mayer, Angela Leis, Ferran Sanz
Pageof 14